Radiation inhibition of arterial restenosis: A new frontier

Acta Oncologica

Volumn 38, Issue 4, 1999, Pages 407-424

  Rubin, Philip ^a   Williams, Jacqueline P ^a   Schell, Michael C ^a   Okunieff, Paul ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; ATHERECTOMY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW;

CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; EVALUATION STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS;

EID: 0033015447     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431933     Document Type: Review

References (146)

1. 1. Baim DS. Interventional catheterization techniques: percutaneous transluminal balloon angioplasty, valvuloplasty, and related procedures. In: Braunwald E, ed. Heart disease - a textbook of cardiovascular medicine. Philadelphia: Saunders, 1992: 1365-81.
2. 2. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994; 331: 1037-43.
3. 3. King SB, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST), N Engl J Med 1994; 331: 1044-50.
4. 4. King SB, Barnhart HX, Kosinski AS, et al. Angioplasty or surgery for multivessel coronary artery disease; comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 1997; 79: 1453-9.
5. 5. Block PC. Restenosis after percutaneous transluminal coronary angioplasty anatomic and pathophysiological mechanisms. Strategies for prevention. Circulation 1990; 81: IV2-IV4.
6. 6. Serruys PW, Luijten HE, Beatt KJ, et al. Incidente of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77: 361-71.
7. 7. Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty. Circulation 1991; 83: 128-41.
8. 8. Hofling B, Huchns TY, Gonschior P, Nikol S. Drug and instrumental therapeutic approaches for prevention of restenosis. Zeitschrift fur Kardiologie 1995; 84 (Suppl 4): 151-8.
9. 9. Franklin SM, Faxon DP. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. Coronary Artery Disease 1993; 4: 232-42.
10. 10 National Center for Health Statistics, Vital and Health Statistics. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990, 1774th ed. Hyattsville; US Department of Health and Human Services, 1992: 111.
11. 11. Nath R, Roberts KB. Vascular irradiation for the prevention of restenosis after angioplasty: a new application for radiotherapy. Int J Radiat Oncol Biol Phys 1996; 36: 977-9.
12. 12. Weintraub WS. Evaluating the cost of therapy for restenosis; considerations for brachytherapy. Int J Radiat Oncol Biol Phys 1996; 36: 949-58.
13. 13. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501.
14. 14. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-95.
15. 15. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993; 22: 135-43.
16. 16. Topaz O, Vetrovec GW. The stenotic stent; mechanisms and revascularization options. Cathet Cardiovasc Diag 1996; 37: 293-9.
17. 17. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.
18. 18. Hoffmann R, Mintz GS, Kent KM, et al. Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz Schatz stents. Am J Cardiol 1997; 79: 951-3.
19. 19. Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994; 15: 781-5.
20. 20. Bonan R, Paiement P, Leung TK. Swine model of coronary restenosis: effect of a second injury. Cathet Cardiovasc Diag 1996; 38: 44-9.
21. 21. Nori D, Parikh S, Moni J. Management of peripheral vascular disease: innovative approaches using radiation therapy. Int J Radiat Oncol Biol Phys 1996; 36: 847-56.
22. 22. Order SE, Donaldson, eds. Radiation therapy of benign diseases. A clinical guide. Heidelberg: Springer-Verlag, 1990.
23. 23. Appleton I, Brown NJ, Willoughby DA, Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 1996; 149: 1441-7.
24. 24. Kischer CW. The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicr Cyt Pathol 1992; 24: 281-96.
25. 25. Borok TL, Bray M, Sinclair I, Plafker J, LaBirth L, Rollins C. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys 1988; 15: 865-70.
26. 26. Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys 1989; 17: 77-80.
27. 27. Gregoritch SJ. Prevention of heterotopic ossification: a paradigm for the evolving role of radation therapy in benign disease. Int J Radiat Oncol Biol Phys 1996; 36: 981-3.
28. 28. MacLennan I, Keys HM, Evarts CM, Rubin P. Usefulness of postoperative hip irradiation in the prevention of heterotopic bone formation in a high risk group of patients. Int J Radiat Oncol Biol Phys 1984; 10: 49-53.
29. 29. Blount LH, Thomas BJ, Tran L, Selch MT, Sylvester JE, Parker RG. Postoperative irradiation for the prevention of heterotopic bone: analysis of different dose schedules and shielding considerations. Int J Radiat Oncol Biol Phys 1990; 19: 577-81.
30. 30. Konski A, Pellegrini V, Poulter C, et al. Randomized trial comparing single dose versus fractionated irradiation for prevention of heterotopic bone: a preliminary report. Int J Radiat Oncol Biol Phys 1990; 18: 1139-42.
31. 31. Milas L, Ito H, Hunter N, Jones S, Peters I.J. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type. Cancer Res 1986; 46: 723-7.
32. 2H nuclear magnetic resonance studies. Cancer Res 1991; 51: 3289-95.
33. 33. Bernstein EF, Sullivan FJ, Mitchell JB, Salomon GD, Glatstein E. Biology of chronic radiation effect on tissues and wound healing. Clin Plastic Surg 1993; 20: 435-53.
34. 34. Vegesna V, Withers HR, Holly FE, McBride WH. The effect of local and systemic irradiation on impairment of wound healing in mice. Radiat Res 1993; 135: 431-3.
35. 35. Hall EJ, ed. Radiobiology for the radiologist. 4th ed. Philadelphia: Lippincott, 1994.
36. 36. Perez CA, Brady LW, Roti Roti JL. Overview, In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott, 1997: 1-78.
37. 37. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374-87.
38. 38. Majesky MW, Schwartz SM, Clowes MM, Clowes AW. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 1987; 61: 296-300.
39. 39. London SM, Mayberg MR. Kinetics of bromodeoxyuridine uptake by smooth muscle cells after arterial injury. J Vasc Res 1994; 31: 247-55.
40. 40. Raithel D. Recurrent carotid disease: optimum technique for redo surgery. J Endovasc Surg 1996; 3: 69-75.
41. 41. Vasquez G, Occhionorelli S, Santini M, Mascoli F. Intimal hyperplasia following vascular procedure. An unresolved problem. Minerva Cardioangiol 1995; 43: 111-6.
42. 42. Davies MG, Hagen PO. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 1995; 9: 7-18.
43. 43. Sacks D, Robinson ML, Summers TA, Marinelli DL. The value of duplex sonography after peripheral artery angioplasty in predicting subacute restenosis. Am J Roentgenol 1994; 162: 179-83.
44. 44. Schopohl B, Liermann D, Pohlit LJ, et al. 1921r endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stem implantation in peripheral vessels: 6 years of experience. Int J Radiat Oncol Biol Phys 1996; 36: 835-40.
45. 45. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 1990; 82: 2190-200.
46. 46. Schwartz RS. The vessel wall reaction in restenosis. Semin Intervent Cardiol 1997; 2: 83-8.
47. 47. Wilcox JN, Waksman R, King SB, Scott NA. Role of the adventitia in the arterial response to angioplasty. In: Waksman R, King SB, Crocker IR, Mould RF, eds. Vascular brachytherapy. Veenendal: Nucleotron, 1996: 17-29.
48. 48. Schieffer E, Chronos NAF, Robinson KA, King SB, Neointima,adventitia and remodeling after balloon injury of porcine arteries (abstract). Eur Heart J 1996; 17: 219.
49. 49. Klagsbrun M. Vascular cell growth factors and the arterial wall. In: Haber E, ed. Molecular cardiovascular medicine. New York: Scientific American, 1995: 63-78.
50. 50. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 1989; 58: 575-606.
51. 51. Winkles JA, Friesel R, Burgess WH, et al. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 1987; 84: 7124-8.
52. 52. Ross R. Arteriosclerosis: an overview. In: Haber E, ed. Molecular cardiovascular medicine. New York: Scientific American, 1995: 11-30.
53. 53 Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1989; 1: 207-35.
54. 54. Faries PL, Marin ML, Veith FJ, et al. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J Vasc Surg 1996; 24: 463-71.
55. 55. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-36.
56. 56. Virchow R. Phlogose und Thrombose im Gofasssystem. Gesammelte Abhandlugen zur Wissenschaftlichen Medizin. Frankfurt-am-Mein: Meidinger Sohn, 1856.
57. 57. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol 1977; 86: 675-84.
58. 58. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976; 295: 369-77.
59. 59. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 1976; 295: 420-5.
60. 60. Simionescu M, Simionescu N. Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J 1993; 7: 1359-66.
61. 61. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992; 86: 11147-11152.
62. 62. Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993; 14 (K Suppl): 2-6.
63. 63. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol 1996; 16: 34-43.
64. 64. Ueda M, Becker AE, Fujimoto T, Tsukada T. The early phenomena of restenosis following percutaneous transluminal coronary angioplasty. Eur Heart J 1991; 12: 937-45.
65. 65. Hansson GK. Immunological control mechanisms in plaque formation. Basic Res Cardiol 1994; 89 (I Suppl): 41-6.
66. 66. Harker LA, Ross R, Glomset J. Role of the platelet in atherogenesis. Ann NY Acad Sci 1976; 275: 321-9.
67. 67. Taubman MB, Rollins BJ, Poon M, et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res 1992; 70: 314-25.
68. 68. Bowen-Pope DF, Ross R, Seifert RA. Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets. Circulation 1985; 72: 735-40.
69. 69. Grotendorst GR, Chang T, Seppa HE, Kleinman HK, Martin GK. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol 1982; 113: 261-6.
70. 70. Wilcox JN, Waksman R, King SB, Scott NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys 1996; 36: 789-96.
71. 71. Waksman R, Rodriguez JC, Robinson KA, et al. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997; 96: 1944-52.
72. 72. Gonschior P, Gerheuser F, Lehr HA, Welsch U, Hofling B. Ultrastructural characteristics of cellular reaction to experimental catheter-induced lesions of arterial blood vessels. Vasa 1995; 24: 325-32.
73. 73. Gonschior P, Gerheuser F, Lehr HA, Welsch U, Hofling B. Ultrastructural characteristics of cellular reaction after experimentally induced lesions in the arterial vessel. Basic Res Cardiol 1995; 90: 160-6.
74. 74. Brenner DJ, Miller RC, Hall EJ. The radiobiology of intravascular irradiation. Int J Radiat Oncol Biol Phys 1996; 36: 805-10.
75. 75. Hanke H, Hassenstein S, Ulmer A, et al. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J 1994; 15: 691-8.
76. 76. Saxena U, Goldberg IJ. Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment. Curr Op Lipidol 1994; 5: 316-22.
77. 77. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992; 140: 301-16.
78. 78. Couffinhal D, Duplaa C, Moreau C, Lamaziere JM, Bonnet J. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 1994; 74: 225-34.
79. 79. Rubin P, Williams JP, Riggs PN, et al. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part 1: Role of the macrophage and platelet-derived growth factor. Int J Radiat Oncol Biol Phys 1998; 40: 929-41.
80. 80. Rosen EM, Goldberg ID, Myrick KV, Levenson S. Radiation survival properties of cultured vascular smooth muscle cells. Radiat Res 1984; 100: 182-91.
81. 81. Shimotakahara S, Mavberg MR. Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke 1994; 25: 424-8.
82. 82. Mayberg MR, Luo Z, London S, Gajdusek C, Rasey JS. Radiation inhibition of intimal hyperplasia after arterial injury. Radiat Res 1995; 142: 212-20.
83. 83. Tanaka H, Sukhova G, Schwartz D, Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 1996; 16: 12-8.
84. 84. Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 1995; 92: 2995-3005.
85. 85. Rubin P, Casarett GW, eds. Clinical radiation pathology. Philadelphia: Saunders, 1968.
86. 86. Crocker IR, Waksman R, Robinson KA, Cipolla GD, King SB. Low-dose endovascular irradiation inhibits restenosis following angioplasty in swine model (abstract). Radiology 1994; 193 (P Suppl): 615C.
87. 87. Herbaux B, Bethouart M, Rohart J, Bilterys L, Triboulet JP. Effets des irradiation sur les sutures microchirurgicales vasculaires. J Chir (Paris) 1983; 120: 115-23.
88. 88. Kalovidouris AE, Papayannis AG. Effect of ionizing radiation on platelet function in vitro. Acta Radiol Oncol 1981; 20: 333-6.
89. 89. Ebbe S, Phalen E, Yee T. Postirradiation thrombocytopoiesis: suppression, recovery, compensatory states, and macromegakaryocytosis. Prog Clin Biol Res 1986; 215: 71-89.
90. 90. Davey RJ. Transfusion-associated graft-versus-host disease and the irradiation of blood components. Immunol Invest 1995; 24: 431-4.
91. 91. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-93.
92. 92. Ryan TA. Endovascular brachytherapy: the FDA's perspective. Int J Radiat Oncol Biol Phys 1996; 36: 992-3.
93. 93. Verin V, Popowski Y, Urban P, et al. Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 1995; 92: 2284-90.
94. 94. Friedman M, Felton L, Byers S. The antiatherogenic effect of iridium 192 upon the cholesterol-fed rabbit. J Clin Invest 1964; 43: 185-92.
95. 95. Friedman M, Byers SO. Effects of iridium 192 radiation on thromboatherosclerotic plaque in the rabbit aorta. Arch Pathol 1965; 80: 285-91.
96. 96. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J, Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23: 1491-8.
97. 97. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. J Am Coll Cardiol 1995; 25: 1451-6.
98. 98. Wiedermann JG, Leavy JA, Amols H, et al. Effects of high-dose intracoronary irradiation on vasomotor function and smooth muscle histopathology. Am J Physiol 1994; 267: 11125-32.
99. 99. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiation therapy in restenosis prevention. Circulation 1995; 91: 1533-9.
100. 100. Mazur W, Ali MN, Khan MM, et al. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol Biol Phys 1996; 36: 777-88.
101. 101. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. Circulation 1995; 92: 3025-31.
102. 102. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation 1995; 92: 1383-6.
103. 103. Waksman R, Robinson KA, Crocker IR, et al. Efficacy and safety of beta versus gamma radioisotopes for endovascular irradiation in prevention of intimal hyperplasia after balloon angioplasty in swine coronaries (abstract). Circulation 1995; 92: 81-146.
104. 104. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary radiation decreases the second phase of intimal hyperplasia in a repeat balloon angioplasty model of restenosis. Int J Radiat Oncol Biol Phys 1997; 39: 475-80.
105. 105. Weshler Z, Gotsman MS, Okon E, et al. Inhibition by irradiation of smooth muscle cell proliferation in the de-endothelialized rat aorta. Front Radiat Biol 1988; 133-8.
106. 106. Weshler Z, Uretzky G, Okon E, et al. Prevention of neointimal proliferation by ionizing irradiation (abstract). Proc Int Congress Radiol 1989; 352.
107. 107. Schwartz RS, Koval TM, Edwards WD, et al. Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury. J Am Coll Cardiol 1992; 19: 1106-13.
108. 108. Koh WJ, Mayberg MR, Chambers J, et al. The potential role of external beam radiation in preventing restenosis after coronary angioplasty. Int J Radiat Oncol Biol Phys 1996; 36: 829-34.
109. 109. Hirai T, Korogi V, Harada M, Takahashi M. Prevention of intimal hyperplasia by irradiation. An experimental study in rabbits. Acta Radiol 1996; 37: 229-33.
110. 110. Schafer U, Micke O, Dorszewski A, Breithardt G, Willich N. The influence of single and fractionated dose external beam irradiation on injury-induced arterial smooth muscle cell proliferation (abstract). Int J Radiat Oncol Biol Phys 1997; 39: 2182.
111. 111. Sarac TP, Riggs PN, Williams JP, et al. The effects of low-dose radiation on neointimal hyperplasia. J Vasc Surg 1995; 22: 17-24.
112. 112. Gellman J, Healey G, Chen Q, et al. The effect of very low dose irradiation on restenosis following balloon angioplasty. A study in the atherosclerotic rabbit (abstract). Circulation 1991; 83 (Suppl I): 1319.
113. 113. Hehrlein C, Kaiser S, Kollum M, Kinscherf R, Metz J, Fritz P. External beam irradiation fails to inhibit neointima formation in stented rabbit arteries (abstract). Circulation 1996; 94 (Suppl I): 1219.
114. 114. Rege S, Razavi M, Fessenden K. ASTRO Research Fellowship: low dose radiation to prevent restenosis after angioplasty (abstract). Int Radiat Oncol Biol Phys J 1997; 39 (Suppl 2S): 1935.
115. 115. Styles TJ, Maijianowski MMH, Robinson KA, et al. Effects of external irradiation of the heart on the coronary artery response to balloon angioplasty injury in pigs (abstract). Int J Radiat Oncol Biol Phys 1997; 39 (Suppl 2S): 2181.
116. 116. Kutryk MJB, Serruys PW. Current indications for stenting. In: Kutryk MJB, Serruys PW, eds. Current state of coronary stenting. Rotterdam; Barjesteh van Waalwijk van Doorn, 1997; 69-79.
117. 117. Satler LF. 'Remedies' for in-stent restenosis. Catheter Cardiovasc Diag 1996; 37: 320-1.
118. 118. Hoffmann R, Mintz GS, Popma JJ, et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz Schatz stents in native coronary arteries. J Am Coll Cardiol 1996; 28: 1134-9.
119. 119. Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz Schatz stents. J Am Coll Cardiol 1993; 21: 26-34.
120. 120. Luo H, Nishioka T, Eigler NL, et al. Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction. Arterioscler Thromh Vasc Biol 1996; 16: 1393-8.
121. 121. Andersen HR, Maeng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation 1996; 93: 1716-24.
122. 122. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
123. 123. Hehrlein C, Zimmermann M, Metz J, Fehsenfeld P, von Hodenberg E. Radioactive coronary stent implantation inhibits neointimal proliferation in nonatherosclerotic rabbits (abstract). Circulation 1993; 88: 651.
124. 124. Laird JR, Carter AJ, Kufs WM, et al. Inhibition of neointimal proliferation with low-dose irradiation from a (-particle-emitting stent. Circulation 1996; 93: 529-36.
125. 125. Hehrlein C, Stintz M, Kinscherf R, et al. Pure (-particle-emitting stents inhibit neointima formation in rabbits. Circulation 1996; 93: 641-5.
126. 126. Fischell TA, Kharma BK, Fischell DR, et al. Low-dose, beta-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation. Circulation 1994; 90: 2956-63.
127. 127. Carter AJ, Laird JR, Bailey LR, et al. Effects of endovascular radiation from a ß-particle-emitting stent in a porcine coronary restenosis model. A dose-response study. Circulation 1996; 94: 2364-8.
128. 128. Fischell TA, Carter AJ, Laird JR. The (-particle-emitting radioisotope stent (isostent): animal studies and planned clinical trials. Am J Cardiol 1996; 78: 45-50.
129. 129. Hehrlein C, Gollan C, Donges K, et al. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995; 92: 1570-5.
130. 130. Carter AJ, Scott D, Bailey LR, Jones R, Fischell TA, Virmani R. High activity 32P stents promote the development of atherosclerosis at six months in a porcine coronary model (abstract). Circulation ; : I 1997; 96: 607.
131. 131. Hehrlein C. European clinical experience using the P-32 stent (abstract). Proc Adv Cardiovasc Radiat Ther, March 8-10 1998; 217.
132. 132. Massullo V, Teirstein PS, Jani S, et al. Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the SCRIPPS coronary radiation to inhibit proliferation post stenting trial. Int J Radiat Oncol Biol Phys 1996; 36: 973-5.
133. 133. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-703.
134. 134. Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-32.
135. 135. Teirstein PS. Intracoronary gamma radiation and stents for restenotic lesions; the SCRIPPS clinical experience (abstract). Proc Adv Cardiovasc Radiat Ther, March 8-10 1998; 265-8.
136. 136. Condado J. Clinical and angiographic follow-up after intracoronary gamma irradiation (abstract). Proc Adv Cardiovasc Radiat Ther, March 8-10 1998; 276.
137. 137. Verin V, Urban P, Popowski Y, et al. Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation 1997; 95: 1138-44.
138. 138. King SB, III. Clinical trial design. Semin Intervent Cardiol 1997; 2: 139-44.
139. 139. Böttcher HD, Schopohl B, Liermann D, Kollath J, Adamietz IA. Endovascular irradiation - a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiat Oncol Biol Phys 1994; 29: 183-6.
140. 140. Steidle B. Preventive percutaneous radiotherapy for avoiding hyperplasia of the intima following angioplasty together with stent implantation. Strahlenther Onkol 1994; 170: 151-4.
141. 141. Liermann D, Böttcher HD, Kollath J, et al. Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol 1994; 17: 12-6.
142. 142. Liermann DD, Bauersachs R, Schopohl B, Böttcher HD. Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Intervent Cardiol 1997; 2: 133-7.
143. 143. Nath R. Recommendations from the AAPM Task Group 60 on intravascular brachytherapy (abstract). Proc Adv Cardiovasc Radiat Ther. March 1998; 8 10: 190-1.
144. 144. Mohan R, Wang X, Jackson A. Optimization of 3-D conformal radiation treatment plans. Front Radiat Ther Oncol 1996; 29: 86-103.
145. 145. Leibel SA, Ling CC, Kutcher GJ, Mohan R, Cordon-Cordo C, Fuks Z. The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 805-11.
146. 146. Williams JP, Eagleton M, Green RM, Rubin P. Effectiveness of fractionated external irradiation on the angioplastied rat carotid (abstract). Proc Adv Cardiovasc Radiat Ther, March 8-10 1998; 16.